Urinary Tract Infection Testing Market Report

Urinary Tract Infection Testing Market Size and Trends:

The global urinary tract infection testing market size was valued at USD 622.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 877.0 Million by 2033, exhibiting a CAGR of 3.89% during 2025-2033. North America currently dominates the market, holding a significant market share of over 35.0% in 2024. The urinary tract infection testing market share is primarily driven by the rising prevalence of urinary tract infections among women, increasing awareness about the benefits of timely diagnosis, and improvements in healthcare infrastructure.

The global urinary tract infection testing market growth is being driven by several key factors, including the rising prevalence of UTIs worldwide, particularly among women and the geriatric population. According to industry reports, the number of individuals aged 60 years and above accounted for 12% of the total global population in 2024, equating to approximately 1.2 Billion. In addition to this, increased awareness about the importance of early diagnosis and treatment is propelling the demand for UTI testing products. Besides that, the growing focus on preventive healthcare, along with an expanding healthcare infrastructure, is further boosting the market. The rise in healthcare expenditure and improved healthcare access in emerging economies are also contributing to industry expansion.

The United States has emerged as a key regional market for urinary tract infection testing, mainly due to the high prevalence of UTIs, especially in women, and growing knowledge about the significance of timely diagnosis and treatment. The use of cutting-edge technologies, such as rapid testing kits and point-of-care diagnostics, has also made UTI diagnosis faster and more accessible. As per a report published by the IMARC Group, the United States point-of-care diagnostics market is forecasted to exhibit a CAGR of 6.90% during 2024-2032. Besides this, the growing emphasis on preventive healthcare, the rise in healthcare spending, and improvements in healthcare infrastructure across the country are also supporting market growth.

Urinary Tract Infection Testing Market Trends:

Increasing prevalence of urinary tract infections (UTIs)

One of the primary reasons driving the urinary tract infection testing market demand is the increasing prevalence of urinary tract infections worldwide. UTIs are the most common type of bacterial infections and are most prevalent in women, children, and older adults, although women are at a higher risk due to the shorter length of their urethra. According to industry reports, approximately 50-60% of women suffer from a urinary tract infection (UTI) at least once in their lifetime. The prevalence of these diseases is also gradually increasing because of factors involving lifestyle changes and increasing geriatric populations. As the infection rate rises, the need for timely and accurate diagnostic tests increases further, driving the market for UTI testing products worldwide.

Technological advancements in diagnostic tools

Technological innovations in UTI testing and rapid diagnostic tools are creating a positive urinary tract infection testing market outlook. Traditional methods used in diagnosing UTIs, such as urine culture, can take several days before results appear. However, innovations such as rapid urine test kits, molecular diagnostic tools, and point-of-care testing devices make it possible to receive the result much sooner. As per a report published by the IMARC Group, the global point-of-care diagnostics market size is projected to exhibit a CAGR of 7.6% during 2025-2033. These technologies offer the benefit of point-of-diagnosis convenience, hence making the tests more accessible, efficient, and cost-effective. The adoption of these next-generation technologies throughout healthcare settings in clinics, hospitals, and in-home care environments is driving the market for UTI testing globally.

Growing healthcare awareness and preventive measures

The urinary tract infection testing market trends indicate that the increasing awareness about the importance of early detection and preventive healthcare is fueling the demand for these solutions. Since many individuals are becoming aware of the damage that an untreated UTI might cause, such as kidney damage or even sepsis, there is now a focus on early diagnosis and treatment. Public health initiatives, media campaigns, and education programs are also educating individuals on the symptoms and potential complications related to UTIs, particularly high-risk demographics such as pregnant women and the elderly. As per industry reports, from 2018-19 to 2022-23, more than 1.8 Million hospitalizations were related to UTIs, with most of these individuals being 65 years of age or older. All this awareness will lead to an increase in rates of diagnosis and testing, further augmenting market demand.

Urinary Tract Infection Testing Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global urinary tract infection testing market, along with forecasts at the global and regional levels from 2025-2033. The market has been categorized based on test type, infection type, test kit, and end user. 

Analysis by Test Type:

• Urinalysis
• Urine Cultures
• Susceptibility Testing

Urinalysis stands as the largest component in 2024. Urinalysis currently leads the urinary tract infection testing market share for several reasons, such as its efficiency, low cost, and non-invasiveness. Rapid detection of the presence of bacteria, white blood cells, or other symptoms that indicate infections through urine samples has made the use of urinalysis essential in clinics and hospitals for providing immediate responses, which facilitate quick decisions and appropriate treatment. Besides this, urinalysis is relatively inexpensive compared with other diagnostic techniques. Therefore, it is available for a large population of patients. Overall, high sensitivity and low cost have propelled the dominance of urinalysis in the urinary tract infection testing market.

Analysis by Infection Type:

• Urethritis
• Cystitis
• Pyelonephritis

Cystitis leads the market with around 42.0% of market share in 2024. Being highly prevalent and therefore with a critical clinical impact, cystitis, an inflation of the bladder, dominates the market. Cystitis most frequently has leading symptoms such as frequent urination, accompanied by pain, which are considered the most direct indications for any person to get medically diagnosed and treated. Diagnostic approaches to cystitis need to separately address this issue from a group of generally possible urinary system conditions. This prevalence of cystitis, particularly among women, makes it a prominent segment in the urinary tract infection testing market, increasing the demand for appropriate and timely testing to diagnose and treat the condition.

Analysis by Test Kit:

• Home Test Kits
• Laboratory Test Kits

Laboratory test kits represent the leading market segment in 2024. Laboratory test kits are dominating the urinary tract infection testing market because of their accuracy, reliability, and provision of detailed results. The kits usually provide urine culture tests and dipstick analysis, all aimed at bacterial pathogens causing infections. Laboratory kit test sensitivity is highly specific, and it ensures accurate diagnosis without any deviation for proper management. They are widely used in hospitals, clinics, and diagnostic laboratories. The increasing demand for accurate, speedy, and painless UTI diagnosis further drives the use of laboratory test kits, which serve as the clinical data source guiding patient care.

Analysis by End User:

• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

According to the urinary tract infection testing market forecast, hospitals exhibit a clear dominance, accounting for 30.0% of market share in 2024. Hospitals hold the majority of the market for urinary tract infection testing due to the range of healthcare they offer, their superior diagnostic technology, and professional expertise in specialized medicine. Since a hospital is considered a center for primary patient care, they have highly developed laboratories to perform more precise and comprehensive UTI tests, including urine culture and microscopy. Hospitals also offer emergency medical care for complications of UTI, such as pyelonephritis or sepsis. This has to be promptly diagnosed and treated. These factors, combined with the large number of patients who are now consulting their physicians regarding UTI symptoms, cement hospitals as leaders in the urinary tract infection testing market.

Regional Analysis:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

In 2024, North America accounted for the largest market share of over 35.0%. The region has the best healthcare infrastructure and the highest expenditure on healthcare and has easy access to medical facilities. North America also has the best diagnostic facilities in the world, with an increasing interest in early diagnosis and treatment of UTIs. Further, the awareness regarding urinary health among women and an aging population vulnerable to infections results in a stable demand for UTI testing. In addition to this, market growth is also driven by the presence of key market players in the region, ongoing research and development (R&D) by different organizations, and support provided by the government for healthcare innovations.

Key Regional Takeaways:

United States Urinary Tract Infection Testing Market Analysis

In 2024, the United States accounts for over 92.70% of the urinary tract infection testing market in North America. The urinary tract infection testing market in the United States is dominated by the rise in prevalence of UTIs, particularly in women and older age groups. A rise in lifestyle factors, including increased antibiotic use, sexual activity, and delayed urination, contributes to increased frequency of UTIs. Moreover, increasing age in Americans increases vulnerability toward urinary tract infection, thus providing a further boom to the growth of UTI diagnostics. The Population Reference Bureau projects that, by 2050, the number of American citizens who are 65 years of age and older will rise to 82 Million, recording a substantial growth from 2022, at 58 Million. In tandem with this, advancements in diagnostic tools, including the development of non-invasive, point-of-care tests, are propelling the market forward. These innovations increase accessibility and decrease the time it takes for results, thereby facilitating healthcare providers in diagnosing and treating UTIs in time. In addition, the awareness about UTIs and the significance of early diagnosis has led to increased testing options and, consequently, growth opportunities for the market. The trend toward home diagnostics and telemedicine also adds toward the growth in UTI testing services, where individuals are readily opting for handy solutions due to their hectic schedules.

Asia Pacific Urinary Tract Infection Testing Market Analysis

The urinary tract infection testing market is growing significantly in the Asia Pacific due to a combination of factors such as population growth, rising access to healthcare facilities, and growing awareness regarding health issues. In developing countries such as China and India, with increasing population and urbanization, the incidence of UTIs is increasing among women and children. The India population has stood at 1,395.0 Million as of March 2024, according to the CEIC. Apart from this, an increasing health infrastructure in these countries is expanding diagnostic facilities that facilitate the availability of testing facilities for UTIs. Other than this, a rising incidence of chronic diseases, including diabetes, that increases the vulnerability to urinary tract infections is also expanding the market size in the region. Apart from this, medical professionals in the region are gradually adopting high-end diagnostic technologies such as rapid test kits and automated urinalysis systems, which result in faster and more accurate UTI detection, as individuals are preferring tests that give enhanced convenience with quick results. Besides this, the regional governing agencies are working toward conducting health campaigns in order to educate the public about the dangers that may result from untreated UTIs. This is also stimulating growth in the market through early diagnosis and treatment.

Europe Urinary Tract Infection Testing Market Analysis

The urinary tract infection testing market in Europe is driven by a combination of factors, which include a high incidence of urinary tract infections, an aging population, and advanced healthcare technologies. Since the elderly people in Europe form a significant proportion and are more vulnerable to UTI due to causes such as immobilization, menopause, and comorbid diseases, the testing demand is rising. The estimated EU population was 448.8 Million people, with more than one-fifth (21.3 %) of them being aged 65 years and over as of 1 January 2023, according to industry reports. In addition, the region is equipped with well-established healthcare infrastructure along with huge investments in diagnostic technologies, thus giving way to speedy adaptation of latest UTI testing techniques, which include molecular diagnostics, PCR-based tests, and automated urine analyzers. These tests are quite sensitive and specific and allow detecting the pathogens which cause UTIs at the molecular level. Hence, the disease-causing microbes can be quickly and accurately detected, thereby helping reduce the occurrence of misdiagnosis or treatment delays. Besides, the increasing preference for point-of-care and non-invasive diagnostic testing continues to fuel growth in the market as patients pursue quicker and less painful testing experiences. The increased awareness regarding complications ensuing due to unattended UTIs, such as kidney infection, is also driving individuals toward early testing and hence contributing to the growing requirement for UTI diagnostic services across the region.

Latin America Urinary Tract Infection Testing Market Analysis

The increased access to healthcare and heightened awareness about the need for early detection in Latin America are major market drivers for urinary tract infection testing. There is a growing demand for accurate, affordable, and accessible testing services for UTIs, particularly in women and children. As part of this, expanding healthcare infrastructures, along with advancing diagnostic technology in the Brazil and Mexican healthcare industries, have further expanded access to UTI testing. The International Trade Administration estimates that Brazil is Latin America's biggest healthcare market, with 9.47% of its GDP devoted to healthcare expenditure. That accounts for about USD 161 Billion. As more individuals learn about the complications linked with untreated UTIs, such as kidney damage, more and more opt for testing services, thereby boosting market growth.

Middle East and Africa Urinary Tract Infection Testing Market Analysis

The urinary tract infection testing market in the Middle East and Africa is growing due to better healthcare facilities in this region. Individuals are being increasingly diagnosed with UTIs due to such factors as changed lifestyles, reduced access to clean water in various regions, and increased chronic diseases such as diabetes. According to the IDF, the With the greatest regional incidence rate of 16.2% and the second-highest predicted growth (86%) in the number of diabetic people, by 2045, the Middle East and North Africa region is estimated to have 136 Million people suffering from diabetes. Moreover, investments in the healthcare sector by governing agencies across the region are improving diagnostic services. This, combined with increased testing facilities, is driving demand for UTI testing solutions. Other than this, cultural shifts toward preventive care, along with the use of advanced diagnostic technologies, have supported growth in the market.

Competitive Landscape:

Key players are leading the urinary tract infection testing market growth through various strategic actions, such as new-generation diagnostic tools and technology advancements. Companies continue to invest heavily in the innovative research of fast, sensitive, and non-invasive testing methods involving urine dipsticks, automated systems, and molecular diagnostics. Strategic partnerships with healthcare establishments and research bodies also enhance market access, as well as the pace of product development. The demand for point-of-care testing devices has increased, with home-based UTI testing solutions demand also on the rise, propelling market expansion. Besides this, major companies are engaged in digital platform improvements that improve consumer access and enhance the overall experience for patients.

The report provides a comprehensive analysis of the competitive landscape in the urinary tract infection testing market with detailed profiles of all major companies, including:

• ACON Laboratories Inc.
• Arkray Inc.
• Cardinal Health Inc.
• F. Hoffmann-La Roche Ltd.
• Randox Laboratories Ltd.
• Siemens Healthcare Private Limited (Siemens AG)
• Sysmex Corporation
• Thermo Fisher Scientific Inc.

Latest News and Developments:

• In September 2024, Astek Dx, a startup, is developing an optical test system designed to provide UTI results within one hour. The company is aiming to revolutionize UTI diagnostics with this fast-testing technology. In addition, Astek Dx is raising $15 million to support the development of its innovative solution. The company initially reported a $25 million fundraising target but has since corrected the amount.
• September 2024: Mankind Pharma Ltd. unveiled its latest innovation, ‘RAPID NEWS’ self-test kits, designed to address prevalent health issues, including dengue, urinary tract infections (UTIs), and early menopause. This launch signifies a pivotal step toward accessible healthcare, aiming to empower individuals across India with convenient, private, and rapid testing solutions.
• January 2024: Vivoo, a wellness app that offers tailored dietary and lifestyle recommendations determined by at-home urine tests, has unveiled its digital at-home Urinary Tract Infection (UTI) diagnostic device at the International Consumer Electronics Show (CES) 2024.
• June 2023: Sysmex Corporation introduced a new testing system in Europe, referred to as ‘the System,’ for the quick identification of antimicrobial susceptibility. Using urine samples from individuals suspected of suffering from UTIs, the System determines if bacteria are present or absent and evaluates the efficacy of antimicrobials.
• May 2023: A preliminary diagnostic device been created by scientists and academics at The University of Texas at Dallas. This sensor may enable individuals to promptly diagnose urinary tract infections (UTIs) without waiting up to 48 hours for test results.

Urinary Tract Infection Testing Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the urinary tract infection testing market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the global urinary tract infection testing market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the urinary tract infection testing industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.